Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Alexandra Geffrey, M.D.

Title
Institution
Department
Address

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Herlopian A, Hess EJ, Barnett J, Geffrey AL, Pollack SF, Skirvin L, Bruno P, Sourbron J, Thiele EA. Cannabidiol in treatment of refractory epileptic spasms: An open-label study. Epilepsy Behav. 2020 May; 106:106988. PMID: 32169600.
    Citations:    
  2. Hess EJ, Moody KA, Geffrey AL, Pollack SF, Skirvin LA, Bruno PL, Paolini JL, Thiele EA. Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex. Epilepsia. 2016 Oct; 57(10):1617-1624. PMID: 27696387.
    Citations: 12     Fields:    Translation:Humans
  3. Li P, Boronat S, Geffrey AL, Barber I, Grottkau BE, Thiele EA. Rib and vertebral bone fibrous dysplasia in a child with tuberous sclerosis complex. Am J Med Genet A. 2015 Nov; 167A(11):2755-7. PMID: 26177838.
    Citations: 1     Fields:    Translation:Humans
  4. Geffrey AL, Pollack SF, Bruno PL, Thiele EA. Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy. Epilepsia. 2015 Aug; 56(8):1246-51. PMID: 26114620.
    Citations: 35     Fields:    Translation:Humans
  5. Pollack SF, Geffrey AL, Thiele EA, Shah U. Primary intestinal lymphangiectasia treated with rapamycin in a child with tuberous sclerosis complex (TSC). Am J Med Genet A. 2015 Sep; 167A(9):2209-12. PMID: 25943403.
    Citations: 2     Fields:    Translation:Humans
  6. Geffrey AL, Belt OD, Paolini JL, Thiele EA. Lacosamide use in the treatment of refractory epilepsy in tuberous sclerosis complex. Epilepsy Res. 2015 May; 112:72-5. PMID: 25847341.
    Citations:    Fields:    Translation:Humans
  7. Geffrey AL, Shinnick JE, Staley BA, Boronat S, Thiele EA. Lymphedema in tuberous sclerosis complex. Am J Med Genet A. 2014 Jun; 164A(6):1438-42. PMID: 24668795.
    Citations: 1     Fields:    Translation:Humans
  8. Larson AM, Ryther RC, Jennesson M, Geffrey AL, Bruno PL, Anagnos CJ, Shoeb AH, Thibert RL, Thiele EA. Impact of pediatric epilepsy on sleep patterns and behaviors in children and parents. Epilepsia. 2012 Jul; 53(7):1162-9. PMID: 22594377.
    Citations: 9     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Geffrey's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (41)
Explore
_
Co-Authors (5)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.